Every Spin-Off
DePuy Synthes
AnnouncedJ&J's orthopaedics business: hips, knees, shoulders, trauma and spine, about $9.2bn of 2024 sales.
- Status
- Announced
- Expected
- By mid-2027
- Parent
- Johnson & Johnson (JNJ)
- Spin-off ticker
- To be announced
- Market
- United States
Terms
On the Q3 2026 call J&J said it is on track to separate DePuy Synthes by mid-2027 and is leaning toward a spin rather than a sale.
Key dates
- Intent announced
- Q3 2026 update
- Target
Source documents
- Press releaseAnnouncement release
- PresentationNot yet published
- Form 10 / prospectusNot yet public
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email